ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RDHL Redhill Biopharma Ltd

0.469
0.0377 (8.74%)
After Hours
Last Updated: 09:27:55
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Redhill Biopharma Ltd RDHL NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.0377 8.74% 0.469 09:27:55
Open Price Low Price High Price Close Price Previous Close
0.4376 0.437 0.4634 0.451 0.4313
more quote information »

Recent News

Date Time Source Heading
24/4/202421:00PRNUSRedHill Announces First Patient Enrolled in U.S...
08/4/202423:23PRNUSRedHill Biopharma Announces Full-Year 2023 Results and..
02/4/202422:00PRNUSRedHill Biopharma Announces $1.25 Million Registered Direct..
11/3/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/3/202422:00PRNUSRedHill Announces New USPTO Patent Covering Talicia® Through..
05/3/202423:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202423:00PRNUSRedHill's Opaganib Selected for Evaluation by BARDA and NIH..
21/2/202408:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202423:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202423:00PRNUSRedHill's Opaganib Protects Against Radiation-Induced Lung..
17/2/202400:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
14/2/202408:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/2/202408:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/2/202402:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/1/202404:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/1/202404:46PRNUSRedHill Biopharma Announces Closing of $8 Million Registered..
27/1/202401:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/1/202401:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/1/202401:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/1/202401:05PRNUSRedHill Biopharma Announces $8 Million Registered Direct..
25/1/202422:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/1/202422:00PRNUSRedHill Announces New USPTO Patent Grant for Talicia® for H...
21/12/202300:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202300:45PRNUSRedHill and U.S. Army Announce Opaganib and RHB-107..
12/12/202323:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202323:00PRNUSRedHill Biopharma Regains Compliance with Nasdaq Minimum Bid..
06/12/202323:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/202323:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/202323:00PRNUSRedHill Announces New, Non-Dilutive External Funding of..
02/12/202308:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202323:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202323:00PRNUSRedHill Biopharma Announces FDA Grant of 5-Year U.S. Market..
17/11/202304:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202300:00PRNUSRedHill Biopharma Announces the Transfer of its Listing to..
27/10/202307:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/10/202307:06EDGAR2Form F-3/A - Registration statement by foreign private..
17/10/202307:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/10/202323:13EDGAR2Form F-3 - Registration statement by foreign private issuers
11/10/202300:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202322:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202322:00PRNUSRedHill and U.S. Army Announce Opaganib's Ebola Virus..
29/9/202322:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/9/202306:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/9/202306:15PRNUSRedHill Biopharma Announces Receipt of Nasdaq Notification..
18/9/202321:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/9/202321:00PRNUSRedHill Announces FDA sNDA Approval for Talicia®
05/9/202321:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202321:00PRNUSRedHill Announces New USPTO Notice of Patent Allowance for..
17/8/202321:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

Delayed Upgrade Clock